The effect of the interleukin-1 receptor antagonist Anakinra in patients with osteoarthritis of the hand: The AHOA (Anakinra in hand osteoarthritis) pilot study [Interleukin-1 Receptor-Blockade mit Anakinra zur Therapie der Fingerpolyarthrose Eine randomisierte, doppelblinde, Placebo-kontrollierte Studie]

Trial Profile

The effect of the interleukin-1 receptor antagonist Anakinra in patients with osteoarthritis of the hand: The AHOA (Anakinra in hand osteoarthritis) pilot study [Interleukin-1 Receptor-Blockade mit Anakinra zur Therapie der Fingerpolyarthrose Eine randomisierte, doppelblinde, Placebo-kontrollierte Studie]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 May 2013

At a glance

  • Drugs Anakinra (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms AHOA
  • Most Recent Events

    • 06 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top